Australia markets closed

  • ALL ORDS

    6,971.60
    +28.60 (+0.41%)
     

  • AUD/USD

    0.7660
    -0.0022 (-0.28%)
     

  • ASX 200

    6,739.60
    +28.80 (+0.43%)
     

  • OIL

    66.22
    +0.13 (+0.20%)
     

  • GOLD

    1,687.90
    -10.60 (-0.62%)
     

  • BTC-AUD

    65,402.77
    -967.99 (-1.46%)
     

  • CMC Crypto 200

    1,013.67
    +70.49 (+7.47%)
     
Women's wealth:

YOU'RE INVITED: Breakfast and investing tips

Join Yahoo Finance and Thrive Global to harness your habits and secure your future.

Haim Saban explains why the Fox-Disney merger ‘stumped’ him

Saban Capital Group Chairman & CEO, Haim Saban, joins 'Influencers with Andy Serwer' to discuss consolidation and M&A in the media industry.

Latest stories

  • Velodyne Lidar Announces Executive Appointments to Advance Company’s Continued Global Lidar Market Leadership

    Velodyne Lidar, Inc. announced it has appointed Sinclair Vass as Chief Commercial Officer and promoted Mike Jellen to Chief Strategy Officer.

  • English children head back to school after two months of home learning

    Millions of English children and teenagers headed back to school on Monday for the first time in two months, having endured their second extended stretch of home learning because of a strict national lockdown to slow the spread of COVID-19. The reopening of English schools to all pupils is the first step in a four-stage government plan to ease the lockdown while trying to prevent a new surge in infections after a devastating winter wave that severely strained hospitals. "Getting all schools back has been our priority and the first step of our roadmap back to normality," Prime Minister Boris Johnson said on Twitter.

  • Citi, JPMorgan expect Turkey central bank to hike by up to 100 bps in March

    Citi and JPMorgan are expecting Turkey's central bank to hike rates by as much as 100 basis points in March to help keep inflation pressures in check. Turkey already has the highest interest rates of any major economy, but expectations have emerged of a further rate hike after data last week showed inflation rose above 15% in February to levels it last hit in mid-2019. Citi said it expected a further rate rise of between 50 and 100 basis points at the central bank's monetary policy committee meeting on March 18.

  • Farming of Animals in South Africa, 2020 Market Report - ResearchAndMarkets.com

    The "Farming of Animals in South Africa 2020" report has been added to ResearchAndMarkets.com's offering.

  • WEX Teams up With Ford for New Commercial Fleet Referral Arrangement

    WEX today announced it has reached an agreement to deliver WEX fuel cards to Ford Commercial Solutions fleet customers.

  • Carter’s Teams Up With Ashley Tisdale to Celebrate Expectant Moms With ShowHER Love Ultimate Baby Shower

    Carter’s, Inc. (NYSE: CRI), the largest branded marketer in North America of apparel exclusively for babies and young children, announces "ShowHER Love Dream Shower," a series of exclusive weekly prizes for expecting moms curated in partnership with beloved actress and mom-to-be, Ashley Tisdale.

  • Comstock Mining Announces Notice of 2020 Year End Results and Business Update Webcast Via Zoom

    VIRGINIA CITY, Nev., March 08, 2021 (GLOBE NEWSWIRE) -- Comstock Mining Inc. (the “Company”) (NYSE American: LODE), an emerging leader in climate-smart, sustainable mineral development and production, will host a conference call on Thursday, March 11, 2021 at 8:00 a.m. Pacific Time/11:00 a.m. Eastern Time to report its 2020 year end results and provide a business update. The Webcast will include a moderated Q&A, after the prepared remarks. Please join the event 5-10 minutes prior to the scheduled start time. The link and/or dial-in telephone numbers for the live Webcast are as follows: Join Zoom Meeting https://us02web.zoom.us/j/7437013377 Meeting ID: 743 701 3377 One tap mobile +12532158782,,7437013377# US (Tacoma) +13462487799,,7437013377# US (Houston) Dial by your location +1 253 215 8782 US (Tacoma) +1 346 248 7799 US (Houston) +1 669 900 9128 US (San Jose) +1 301 715 8592 US (Washington DC) +1 312 626 6799 US (Chicago) +1 646 558 8656 US (New York) Meeting ID: 743 701 3377 Find your local number: https://us02web.zoom.us/u/kGBcBXcOw The recording of the Webcast will be available, within 24 hours of the call, on the Company website: http://www.comstockmining.com/investors/investor-library About Comstock Mining Inc. Comstock Mining Inc. (NYSE: LODE) (the “Company”) is an emerging leader in climate-smart, sustainable mineral development and production of environment-enhancing, increasingly scarce strategic and precious metals. The Company is focused on conservation-based, high-value, cash-generating valorization of mineral and metals essential to meeting the rapidly increasing demand for clean energy technologies. The Company has extensive, contiguous property in the historic, world-class Comstock and Silver City mining districts (collectively, the “Comstock District”) with fully permitted, metallurgical labs and an operational, mineral processing and beneficiation platform that includes a growing portfolio of mercury remediation, gold, silver, lithium, nickel, and cobalt processing capabilities. To learn more, please visit www.comstockmining.com. Forward-Looking Statements This press release and any related calls or discussions may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical facts, are forward-looking statements. The words “believe,” “expect,” “anticipate,” “estimate,” “project,” “plan,” “should,” “intend,” “may,” “will,” “would,” “potential” and similar expressions identify forward-looking statements, but are not the exclusive means of doing so. Forward-looking statements include statements about matters such as: consummation of all pending transactions; project, asset or Company valuations; future industry market conditions; future explorations, acquisitions, investments and asset sales; future performance of and closings under various agreements; future changes in our exploration activities; future estimated mineral resources; future prices and sales of, and demand for, our products; future operating margins; available resources; environmental conservation outcomes; future impacts of land entitlements and uses; future permitting activities and needs therefor; future production capacity and operations; future operating and overhead costs; future capital expenditures and their impact on us; future impacts of operational and management changes (including changes in the board of directors); future changes in business strategies, planning and tactics and impacts of recent or future changes; future employment and contributions of personnel, including consultants; future land sales, investments, acquisitions, joint ventures, strategic alliances, business combinations, operational, tax, financial and restructuring initiatives; the nature and timing of and accounting for restructuring charges and derivative liabilities and the impact thereof; contingencies; future environmental compliance and changes in the regulatory environment; future offerings of equity or debt securities; asset sales and associated costs; future working capital, costs, revenues, business opportunities, debt levels, cash flows, margins, earnings and growth. These statements are based on assumptions and assessments made by our management in light of their experience and their perception of historical and current trends, current conditions, possible future developments and other factors they believe to be appropriate. Forward-looking statements are not guarantees, representations or warranties and are subject to risks and uncertainties, many of which are unforeseeable and beyond our control and could cause actual results, developments and business decisions to differ materially from those contemplated by such forward-looking statements. Some of those risks and uncertainties include the risk factors set forth in our filings with the SEC and the following: counterparty risks; capital markets’ valuation and pricing risks; adverse effects of climate changes or natural disasters; global economic and capital market uncertainties; the speculative nature of gold or mineral exploration, including risks of diminishing quantities or grades of qualified resources; operational or technical difficulties in connection with exploration or mining activities; contests over title to properties; potential dilution to our stockholders from our stock issuances and recapitalization and balance sheet restructuring activities; potential inability to comply with applicable government regulations or law; adoption of or changes in legislation or regulations adversely affecting businesses; permitting constraints or delays; decisions regarding business opportunities that may be presented to, or pursued by, us or others; the impact of, or the non-performance by parties under agreements relating to, acquisitions, joint ventures, strategic alliances, business combinations, asset sales, leases, options and investments to which we may be party; changes in the United States or other monetary or fiscal policies or regulations; interruptions in production capabilities due to capital constraints; equipment failures; fluctuation of prices for gold or certain other commodities (such as silver, zinc, cyanide, water, diesel fuel and electricity); changes in generally accepted accounting principles; adverse effects of terrorism and geopolitical events; potential inability to implement business strategies; potential inability to grow revenues; potential inability to attract and retain key personnel; interruptions in delivery of critical supplies, equipment and raw materials due to credit or other limitations imposed by vendors or others; assertion of claims, lawsuits and proceedings; potential inability to satisfy debt and lease obligations; potential inability to maintain an effective system of internal controls over financial reporting; potential inability or failure to timely file periodic reports with the SEC; potential inability to list our securities on any securities exchange or market; inability to maintain the listing of our securities; and work stoppages or other labor difficulties. Occurrence of such events or circumstances could have a material adverse effect on our business, financial condition, results of operations or cash flows or the market price of our securities. All subsequent written and oral forward-looking statements by or attributable to us or persons acting on our behalf are expressly qualified in their entirety by these factors. Except as may be required by securities or other law, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Neither this press release nor any related calls or discussions constitutes an offer to sell, the solicitation of an offer to buy or a recommendation with respect to any securities of the Company, the fund or any other issuer. Contact information: Comstock Mining Inc.P.O. Box 1118 Virginia City, NV 89440ComstockMining.comCorrado De GasperisExecutive Chairman & CEOTel (775) 847-4755degasperis@comstockmining.comZach SpencerDirector of External RelationsTel (775) 847-5272 Ext.151questions@comstockmining.com

  • Liquidity Services Announces Approval of New $10,000,000 Stock Repurchase Program

    BETHESDA, Md., March 08, 2021 (GLOBE NEWSWIRE) -- Liquidity Services, Inc. (NASDAQ: LQDT; www.liquidityservices.com), the world’s largest B2B e-commerce marketplace for business and government surplus, announced today that its Board of Directors has authorized a new share repurchase program of up to $10,000,000 of the Company’s common stock. The repurchase program will commence today and expire on March 31, 2023. The timing and actual number of shares repurchased will depend on a variety of factors, including price, general business and market conditions, and the existence of alternative investment opportunities. The repurchase program will be executed consistent with the Company's capital allocation strategy of prioritizing investment to grow the business over the long term. Under the repurchase program, repurchases can be made from time to time using a variety of methods, including open market purchases, all in compliance with the rules of the United States Securities and Exchange Commission (the “SEC”) and other applicable legal and regulatory requirements. The repurchase program does not obligate the Company to acquire any particular amount of common shares, and the repurchase program may be suspended or discontinued at any time at the Company’s discretion. Forward-Looking StatementsThis document contains forward-looking statements made pursuant to the Private Securities Litigation Reform Act of 1995. These statements are only predictions. The outcome of the events described in these forward-looking statements is subject to known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity (including the extent of our share repurchase activity, if any), performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. These statements include, but are not limited to, statements regarding the Company’s business outlook; expected future results; expected future effective tax rates; and trends and assumptions about future periods. You can identify forward-looking statements by terminology such as “may,” “will,” “should,” “could,” “would,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continues” or the negative of these terms or other comparable terminology. Our business is subject to a number of risks and uncertainties, and our past performance is no guarantee of our performance in future periods. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. There are several risks and uncertainties that could cause our actual results to differ materially from the forward-looking statements in this document. Important factors that could cause our actual results to differ materially from those expressed as forward-looking statements are set forth in our filings with the SEC from time to time, and include, among others, potential economic and operational impacts related to the COVID-19 pandemic, especially if there is a rise in COVID-19 deaths that precipitates re-closures or extended restrictions on international travel; the impact of the COVID-19 pandemic on our Company, our employees, our sellers and buyers, and global supply chains; disruptions of transactions due to the COVID-19 pandemic, including the impact of such disruptions on the Company’s ability to generate profits, stabilize or grow GMV or accurately forecast transactions; disruptions in the Company’s workforce as a results of the Company’s efforts to limit of the impact of the COVID-19 pandemic on the Company’s operations and financial condition; and the risks and uncertainties set forth in the Company’s Annual Report on Form 10-K for the year ended September 30, 2020 and in the Company’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2020, which is available on the SEC and Company websites. There may be other factors of which we are currently unaware or which we deem immaterial that may cause our actual results to differ materially from the forward-looking statements. All forward-looking statements attributable to us or persons acting on our behalf apply only as of the date of this document and are expressly qualified in their entirety by the cautionary statements included in this document. Except as may be required by law, we undertake no obligation to publicly update or revise any forward-looking statement to reflect events or circumstances occurring after the date of this document or to reflect the occurrence of unanticipated events. About Liquidity ServicesLiquidity Services (NASDAQ:LQDT) operates leading e-commerce marketplaces that enable buyers and sellers to transact in an efficient, automated environment offering over 600 product categories. The company employs innovative e-commerce marketplace solutions to manage, value and sell inventory and equipment for business and government sellers. Our superior service, unmatched scale and ability to deliver results enable us to forge trusted, long-term relationships with over 14,000 sellers worldwide. With over $8 billion in completed transactions, and more than 3.8 million buyers in almost 197 countries and territories, we are the proven leader in delivering smart B2B e-commerce solutions. Contact:Investor Relations800-310-4604investorrelations@liquidityservicesinc.com

  • BWXT and GMS Form Joint Venture in Nuclear Medicine Manufacturing and Distribution in the Asia-Pacific Region

    BWXT and GMS Form Joint Venture in Nuclear Medicine Manufacturing and Distribution in the Asia-Pacific Region

  • Surgical Imaging Arms Global Market Report 2021: COVID-19 Growth And Change

    Major players in the surgical imaging arms market are GE Healthcare, Hologic Inc. , ATON GmbH, Whale Imaging Inc. , Siemens Healthcare, Shimadzu Corp. , Canon Medical Systems Corporation, Medtronic plc, Ziehm Imaging, and Philips Healthcare.New York, March 08, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Surgical Imaging Arms Global Market Report 2021: COVID-19 Growth And Change" - https://www.reportlinker.com/p06033662/?utm_source=GNW The global surgical imaging arms market is expected to grow from $1.08 billion in 2020 to $1.19 billion in 2021 at a compound annual growth rate (CAGR) of 10.41%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $1.40 billion in 2025 at a CAGR of 4.20%.The surgical imaging arms market consists of sales of surgical imaging arms and related services by entities (organizations, sole traders, and partnerships) that manufacture surgical imaging arms, a vital component used in the field of surgery, especially for performing minimally invasive procedures. The revenue generated by the entities primarily engaged in research, development, manufacturing, and marketing of surgical imaging arms is included in the market.The surgical imaging arms market covered in this report is segmented by product type into G-arm surgical imaging devices, C-arm surgical imaging devices, O-arm surgical imaging devices; by technology into image intensifier C-arms, flat panel detector C-arms; by application into orthopaedic and trauma surgeries, neurosurgeries, cardiovascular surgeries, gastrointestinal surgeries, other applications; by end-user into hospitals and ambulatory surgical centers, academic research institutes.The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.The high cost of surgical imaging arms is anticipated to hamper market growth during the forecast period.Recently, the prices of surgical arms are increasing owing to constant research and development to introduce new features in the devices.The price of C-arm imaging devices ranges from $25,000 to greater than $70,000.The advanced C-arms such as Siemens Cios Fusion of Siemens Healthcare and OEC 9900 of GE Healthcare range between $1,50,000 and $2,00,000.The average refurbished mini C-arm price ranges between $19,000 and $50,000. Health care settings face challenges with the high costs of these devices that are predicted to hinder the market growth.In 2019, FUJIFILM Corporation, Japan-based multinational photography, medical equipment, and biotechnology company that leverages its imaging and information technology for innovation in healthcare, graphic arts, optical devices, highly functional materials, and other high-tech areas, planned to acquire Hitachi’s diagnostic imaging-related business for approximately $1.63 billion (JPY 179 Billion). Fujifilm will further expand its Medical Systems business by applying its proprietary image processing and AI technologies to Hitachi’s extensive product portfolio. Hitachi, Ltd., a Japan-based multinational conglomerate company that provides solutions using a diagnostics imaging system, IT, and electronic health record.High demand for mini C-arms devices is expected to boost market growth during the forecast period.Globally, companies are engaged in the development and manufacturing of novel equipment that assists surgeons in carrying out surgical procedures smoothly and efficiently.The rising demand for mini C-arms devices can be attributed to features, such as its miniaturized size, easy adaptability in the operation theatre, and lower price than other types of C-arms. For instance, in January 2018, Hologic, Inc. launched the next generation mini C-arm imaging, the Fluoroscan InSight FD Mini C-Arm. On an intuitive 24-inch HD touchscreen, the device delivers the largest image size and highest image resolution available, with the help of features such as high-resolution and low-dose-rate modes. Moreover, in September 2019, OrthoScan Inc. launched TAU 2020 Mini C-arm which introduces the largest screen on the mini C-arm. Minimally invasive tests or surgeries incur low costs and saves between $280 million and $340 million in the USA alone by opting for it. With this, the doses can be saved by minimizing shots to enhance work efficiency. Thus, the rising demand for mini C-arms combined with its easy-to-use features is expected to drive the market growth.Integration of technology for real-time visualization during surgeries is gaining significant popularity in the surgical imaging arms market.With the increasing number of patients requiring surgeries, the scope and complexity of surgical interventions such as image-guided minimally invasive surgery continue to surge.In January 2020, Philips announced major innovations in its Zenition mobile C-arm platform.With the new user interface, the clinician will be able to operate C-arm inside the sterile field, reducing the communication burden with the operator and making it more intuitive to control the system.Moreover, the platform is extended to integrate intravascular ultrasound (IVUS) for peripheral vascular procedures for improving workflow and streamlining the operating room.The countries covered in the market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.Read the full report: https://www.reportlinker.com/p06033662/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

  • UPDATE 1-DuPont to buy Laird Performance Materials for $2.3 bln

    DuPont said on Monday it would buy Laird Performance Materials for $2.3 billion from private equity firm Advent International, as it looks to expand its portfolio of advanced electronic materials. Electronics materials have been a growth area for DuPont as key markets including smart or autonomous vehicles, fifth generation telecommunications, artificial intelligence, internet of things, and high-performance computing gain traction. The estimated one-time cost to achieve these synergies is about $40 million and DuPont expects the deal to be accretive to its operating core earnings margins, free cash flow, and adjusted earnings per share within the first 12 months.

  • Toll from military camp blasts in E. Guinea rises to 30: state TV

    The death toll from accidental explosions at a military camp in Equatorial Guinea rose to 30 on Monday, state television said, after 10 more bodies were found in the ruined site.

  • Global Hydrogels Market Analysis & Forecasts 2020-2025 - Growing Use in Wound Care Products and Drug Delivery Systems (DDS)

    Dublin, March 08, 2021 (GLOBE NEWSWIRE) -- The "Hydrogels - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The global market for Hydrogel is projected to reach US$15.3 billion by 2025, driven by their growing use in wound care products and drug delivery systems (DDS). Defined as a three-dimensional (3D) hydrophilic polymer capable of holding large amounts of water, hydrogel is valuable in biological applications as they resemble natural tissue and their high water content. Strong R&D interest is already underway for hydrogel biomaterials. New developments in hydrogel design and hydrogel synthesis are resulting in the development of hydrogels with mechanical properties. Superporous comb-type grafted hydrogels with fast response times; hybrid graft copolymers based self-assembling hydrogels; protein based hydrogels' and hybrid hydrogels are the emerging new future of smart hydrogel based biomaterials. Stimuli-sensitive hydrogels, especially polypeptide based responsive hydrogels hold promising potential. Protein hydrogel are more biocompatible than synthetic hydrogel as they do not require the use of oxic chemical crosslinkers. This represents a key growth opportunity in the market given that traditional hydrogels have been largely limited by their poor mechanical properties and slow response times to stimuli. Temperature-sensitive hydrogels especially will find attractive opportunities in biomedicine. Wound dressings currently remain a popular application area with hydrogel being effective for treating dry necrotic wounds and rapid healing of burn wounds. Hydrogel enables painless debridement of infected tissue and provides a moist wound environment for faster healing. Chitosan-based hydrogels, in this regard, are growing in popularity for their biocompatible, antimicrobial, and hemostatic effects. Acellular Hydrogel is especially valuable in accelerated healing of third-degree burn wounds and is a welcome substitute for complicated and infection prone skin grafts. Encouraging progress is being made in the use of hydrogels for targeted & controlled drug delivery. Hydrogels can prolong drug release kinetics. Their porosity and aqueous features make them perfect biocompatible drug delivery vehicles. Chitosan-based hydrogels can be loaded with active drug compounds like growth factors or stem cells that are important in providing scaffold for cell growth. The growing focus on controlled and targeted drug delivery systems in the field of cardiology, oncology, immunology, and pain management bodes well for future growth in the market. Some of the physical properties of hydrogel that can be manipulated and tuned to suit drug delivery needs include porosity, swelling and elasticity in response to stimuli such as temperature, solvent quality, pH, electric field; resistance to dissolution; free diffusion of solute molecules in water; among others. These properties help in controlled drug release and protect from drug degradation, thereby making them highly effective vehicles for drug delivery systems. Some of the types of hydrogels development for drug delivery include DNA-hydrogels; supramolecular hydrogels; bio-inspired hydrogels; and multi-functional and stimuli-responsive hydrogels. New emerging uses in contact lenses and tissue engineering will also benefit growth in the market in the coming years. The United States and Europe represent large markets worldwide with a combined share of 52.4% of the market. China ranks as the fastest growing market with a CAGR of 7.3% over the analysis period supported by the government's focus on revolutionizing biomedical engineering in the country. The country today ranks as the top country for biomedical research encouraged by a permissive regulatory climate. Key Topics Covered: I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Expanding Applications and Product Innovations Spur Growth in the Global Hydrogel MarketEmerging Economies to Post Strong GrowthIndustry Witnesses Rise in Demand for Synthetic HydrogelsSynthetic Hydrogels by Polymer Type: A SnapshotGlobal Competitor Market SharesHydrogel Competitor Market Share Scenario Worldwide (in %): 2019Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS 3M Company (USA)ACELITY L.P, Inc. (USA)Ashland, Inc. (USA)Braun Melsungen AG (Germany)Cardinal Health, Inc. (USA)Coloplast A/S (Denmark)ConvaTec, Inc. (USA)Integra LifeSciences Holdings Corporation (USA)Evonik Industries AG (Germany)Gentell, Inc. (USA)Hollister, Inc. (USA)Molnlycke Health Care AB (Sweden)Ocular Therapeutix, Inc. (USA)Sekisui Plastics Co. Ltd. (Japan)Smith & Nephew, Plc (UK) 3. MARKET TRENDS & DRIVERS Innovations Expand Addressable Market for HydrogelsRise in Incidence of Chronic Diseases and High Treatment Costs Drive Demand for Hydrogel Dressings for Wound HealingGlobal Prevalence of WoundsPersonal Care Product: An Evolving Niche MarketConsumer Adoption of Hydrogel Contact Lenses Augurs Well for Market GrowthHydrogels Evolve as Emerging Alternative for Food PackagingAgriculture Sector Depicts Strong Growth PotentialGlobal Water Utilization: Percentage Share Breakdown for Agricultural Practices, Industrial Processes, and Domestic UsageRising Concerns over Polluting Water Resources: An Opportunity for Hydrogels MarketNeed for Wastewater Treatment Presents Opportunity for HydrogelsGrowing Emphasis on Sustainability and Positive Impact on HydrogelsGrowth in Biomedical Applications of HydrogelsHydrogels for Cartilage RegenerationGrowing Need for Targeted Controlled Drug Delivery (TCDD) Drives Importance of HydrogelsHydrogel Nanoparticles: The New Hydrogels for Drug DeliveryEvaporative Cooling Hydrogel Packaging: Increasing Storage Stability of PharmaceuticalsGrowing Focus on Baby Hygiene Products Spells Steady Growth Opportunities for HydrogelsIncreased Demand for Feminine Hygiene ProductsAging Population and the Associated Complications Drive the Demand for HydrogelRise in Demand for Novel Hydrogel Dressings for Wound Healing Propels InnovationsHydrogelTypes of HydrogelNatural HydrogelsSelect Natural Hydrogels: Advantages and DisadvantagesSynthetic HydrogelsSelect Synthetic Hydrogels: Advantages and DisadvantagesHybrid Hydrogels 4. GLOBAL MARKET PERSPECTIVE III. GEOGRAPHIC MARKET ANALYSIS UNITED STATES CANADA JAPAN CHINA FRANCE GERMANY ITALY UNITED KINGDOM SPAIN RUSSIA REST OF EUROPE ASIA-PACIFIC AUSTRALIA INDIA SOUTH KOREA REST OF ASIA-PACIFIC LATIN AMERICA ARGENTINA BRAZIL MEXICO REST OF LATIN AMERICA MIDDLE EAST IRAN ISRAEL SAUDI ARABIA UNITED ARAB EMIRATES REST OF MIDDLE EAST AFRICA IV. COMPETITION Total Companies Profiled: 59 For more information about this report visit https://www.researchandmarkets.com/r/u3qfjv CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

  • Fintech Payoneer's Upcoming SPAC IPO and COVID-19 Challenges

    This fintech is one of the newest members of the SPAC IPO Class of 2021, but it has had some recent challenges.

  • Global Zeolite Market Share, Size, Trends, Industry Analysis Report 2020-2027 - Market Size is Expected to Reach $36.98 Billion - ResearchAndMarkets.com

    The "Zeolite Market Share, Size, Trends, Industry Analysis Report, By Product; By End-Use; By Regions; Segment Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering.

  • Central Banks Face Jumpy Bond Market With 10 Days of Decisions

    (Bloomberg) -- Central banks helped save the world economy from depression as the pandemic struck. Now they are dealing with the hard part: managing the recovery amid a difference of opinion with investors.Optimism that Covid-19 vaccines and continued government stimulus offer an escape from the worst health crisis in a century has sent bond yields soaring and pushed bets on rising inflation in the U.S. to the highest in a decade.That’s shifting the ground underneath monetary policy makers who promise to maintain rock bottom borrowing costs and cheap money well into the expansion. In the next two weeks, the Federal Reserve and European Central Bank as well as their counterparts in Japan, U.K, and Canada are all likely to reiterate those pledges, eager to secure a rebound in hiring and avoid the mistakes of the last crisis when some withdrew support too early.The risk now seems skewed the other way. While policy makers welcome a modest rise in bond yields as a signal of confidence in the economic outlook, they worry an unchecked jump would undercut recoveries. They argue any resurgence in inflation will be based on a temporary correction from last year’s slide and that high unemployment will continue to restrain price pressures.It’s a stark turnaround from a year ago, when the world powered down to fight the Covid-19 pandemic and central banks responded with what’s amounted to an unprecedented $9 trillion of monetary support.“Central banks are facing a new challenge,” said Rob Carnell, chief economist for Asia Pacific at ING Bank NV. “How do they keep justifying easy policy as the recovery continues and the inflation figures pick up?”Canada, ECBThe Bank of Canada is first up with a meeting on March 10 when policy makers are likely to indicate they plan to maintain plenty of stimulus well into any strong recovery. It’s a case that Governor Tiff Macklem laid out last month when he argued policy needs to help foster not only the immediate pickup but also facilitate virus-driven structural changes like digitalization.ECB President Christine Lagarde convenes officials the next day when updated forecasts will highlight how the euro-area economy is lagging the U.S. because of slow vaccine rollouts and extended virus restrictions. That puts the bloc at risk should higher global yields spill over into borrowing costs for companies and households.ECB policy makers have surprised investors by downplaying their concerns so far, saying their bond-buying program is flexible enough to address unwarranted tightening but failing to provide any evidence that they’re accelerating purchases. At the back of their minds though is likely to be the experience of 2011 when interest rates were raised twice to combat faster inflation despite a worsening financial crisis, only for the euro zone to slide into a double-dip recession.Powell PressureAt the Fed’s policy meeting on March 16-17, Chairman Jerome Powell will likely reaffirm his looser for longer stance. Powell repeatedly stressed during remarks on Thursday that the Fed was a long way from its goals and was not close to tightening policy. He also played down a likely rise in inflation this year and ducked questions on a possible response to the recent sharp rise in yields.While the move had “caught’ his attention, he said Fed policy was currently appropriate, though it has tools to respond if there is a material change in the outlook.Transcripts of the Fed’s meetings from 2015, when it last began a tightening cycle, suggested policy makers overestimated the potential for accelerating inflation and underestimated the room still left in the economy to generate jobs.What Bloomberg Economics Says...For the U.S., rising bond yields are largely a reflection of confidence in the strength of the recovery. For much of the rest of the world, the spillover of higher borrowing costs is arriving too soon. The Reserve Bank of Australia has already reacted with bigger bond buys. Others may also have to tweak their policy settings.-- Tom Orlik, chief economistClick here for moreTaper TalkThe Bank of England convenes on March 18. It has lined up a further 150 billion pounds ($208 billion) of asset purchases over 2021 with plans to taper weekly buying later in the year.A hugely stimulative budget from Chancellor Rishi Sunak now has economists further discounting the prospect of negative interest rates and instead looking forward to a tightening of monetary policy.The central bank has said that won’t happen until there is clear evidence that spare capacity is being eliminated and it’s closer to sustainably achieving its 2% inflation target, but in February announced it was considering whether to alter previous guidance that it wouldn’t unwind its asset purchases until the bank rate reached 1.5%.Speaking on Monday, Governor Andrew Bailey reiterated the bank doesn’t intend to tighten monetary policy until there’s clear evidence the economy is absorbing excess capacity. He added that risks to the economy remain tilted to the downside, BOJ, PBOCThen it’s the Bank of Japan’s turn on March 18-19, when officials are scheduled to unveil details of a policy review that will look at how it controls yields, negative rates and asset buying. Governor Haruhiko Kuroda has said the central bank is seeking to make its policy framework more effective by fine tuning it rather than overhauling it.He has also signaled there won’t be any changes to the movement range around the 10-year yield target. Still, Deputy Governor Masayoshi Amamiya ssignaled on Monday that the central bank may seek ways to allow more moves in yields. While developed-world central banks will likely be unified in pledging ongoing stimulus, China’s officials are already signaling the opposite. Guo Shuqing, chairman of the China Banking and Insurance Regulatory Commission -- the top banking regulator -- said on March 2. he’s “very worried” about risks emerging from bubbles in global financial markets and the nation’s property sector, stoking expectations of policy tapering.That was followed by the government setting a conservative growth target of above 6% for the year, well below what economists forecast the nation will achieve, as Premier Li Keqiang on Friday opened the National People’s Congress in Beijing.The tension between inflation and cheap money is already forcing some emerging market central banks to move. Ukraine unexpectedly raised interest rates to counter the highest inflation in more than a year. Brazil is forecast to start raising borrowing costs on March 17 having promised in August to keep its 2% benchmark for the “foreseeable future.”(Adds comments from UK and Japanese central bankers)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • National Grid Transforms its Business with Appirio and Salesforce

    National Grid Transforms its Business with Appirio and Salesforce

  • Pandemic tames Airbnb in Europe's tourist hotspots - for now

    The COVID-19 pandemic has achieved what many mayors across Europe have tried and failed to do: wipe out tens of thousands of Airbnbs from city centres and so help lower rental costs for locals, in some places by as much as 15%. While Europe's cities have long welcomed tourists, critics say the surge of properties listed on short-lettings site Airbnb in recent years had priced many locals out of their own housing markets, turning historic neighbourhoods into soulless spaces. Property management companies and landlords contacted by Reuters in cities including Lisbon, Barcelona, Prague, and Venice said the collapse of tourism in the pandemic meant some hosts had now replaced holidaymakers with mid- to long-term tenants, moved in themselves, or given up properties altogether.

  • US STOCKS-Nasdaq futures slide 2% on inflation jitters

    Futures tracking the Nasdaq 100 index sank 2% on Monday as the passage of a $1.9 trillion COVID-19 relief package by the U.S. Senate lifted bond yields, pressuring richly valued technology stocks and sparking inflation concerns. The Senate on Saturday passed the stimulus package - one of the biggest in U.S. history - and President Joe Biden said he hoped for quick passage of the revised bill by the House of Representatives so he could sign it and send $1,400 direct payments to Americans. Technology-related stocks, including Facebook Inc, Apple Inc and Amazon.com Inc, fell between 1.3% and 3% after bearing the brunt of the sell-off in the past three weeks on fears of higher interest rates as the benchmark 10-year Treasury yield scaled one-year highs.

  • Ultra-low Temperature Freezers Global Market Report 2021: COVID-19 Implications And Growth

    Major players in the ultra-low temperature freezers market are Arctiko, Eppendorf, Esco Micro Pte Ltd, Haier, Helmer Scientific, Bionics Scientific Technologies (P). Ltd, PHC Holdings Corporation, Labcold Ltd, Remi Group, and Stirling Ultracold.New York, March 08, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Ultra-low Temperature Freezers Global Market Report 2021: COVID-19 Implications And Growth" - https://www.reportlinker.com/p06033663/?utm_source=GNW The global ultra-low temperature freezers market is expected to decline from $633.94 million in 2020 to $805.47 million in 2021 at a compound annual growth rate (CAGR) of 27.06%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $1 billion in 2025 at a CAGR of 5.7%.The ultra-low temperature freezers market consists of sales of ultra-low temperature freezers by entities (organizations, sole traders, and partnerships) that manufacture ultra-low temperature freezers.Ultra-low temperature freezers are a form of a freezer that can keep temperatures between-80 and-86 degrees Celsius.An ultra-low temperature freezer is also known as a minus 80 freezer or a negative 80 freezer. Only goods and services traded between entities or sold to end consumers are included.The ultra-low temperature freezers market covered in this report is segmented by type into chest freezers, upright freezers; by application into blood & blood products, organs, pharmaceuticals, forensic, genomic research; by end-user into bio-banks, pharmaceutical and biotechnology companies, academic and research laboratories, others.North America was the largest region in the ultra-low temperature freezers market in 2020. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.The high costs associated with ultra-low temperature (ULT) freezers are expected to hinder the growth of the ultra-low temperature freezers market in the coming years.Ultra-low temperature (ULT) sample storage freezers are a central component of a majority of labs, biobanks, and pharmacies around the world.These units allow the medium to the long-term preservation of numerous biological samples, such as cell extracts, proteins, RNA, or DNA.A fixed temperature of -20 °C or -40 °C can be sustained by a regular upright mechanical freezer, but the majority would operate at -80 °C.To maintain a lower temperature, a stable power source is required that leads to additional energy and operating costs.An upright, mechanical ULT freezer can fluctuate in average operating expenses from $750 to $1000 per year.Therefore, the high costs associated with ultra-low temperature (ULT) freezers incurs huge operational costs that are difficult for small and medium enterprises and hampers the growth of the ultra-low temperature freezers market.In June 2019, PHC Holdings Corporation, a Japan-based healthcare company acquired the anatomical pathology business of Thermo Fisher Scientific for $1.14 billion. The anatomical pathology business acquired by PHC Holdings Corporation will operate as a new stand-alone company under the name Epredia. The new company will continue to provide comprehensive solutions in the anatomical pathology field, including microscope slides, consumables, instruments. Thermo Fisher Scientific is a US-based biotechnology company engaged in manufacturing and selling ultra-low temperature freezers market.The COVID-19 outbreak is propelling the growth of the ultra-low temperature freezer market in the coming years.Scientists are trying hard to create a vaccine and depending on ultra-low temperature freezers and incubators to retain novel coronavirus samples so that they can be recovered whenever appropriate and examined to gain insight into this emerging respiratory illness.For example, the BINDER CO2 freezer is helping researchers and scientists to retain coronavirus samples.These freezers are important because they provide protection and anti-contamination features.Therefore, the COVID-19 outbreak contributed to the growth of the ultra-low temperature freezer market.Major companies operating in the ultra-low temperature freezers sector are focusing on developing technology advanced solutions for ultra-low temperature freezers.For example, in May 2020, Thermo Fisher Scientific, a US-based biotechnology company, launched a new service that gathers and tracks key performance data from the attached TSX Series ULT freezers to provide an optimum sample and product safety.The Thermo Scientific smart connected systems function tracks 37 types of alarms and 26 operational parameters for the user to provide a detailed analysis of the linked TSX Series ULT freezers.The countries covered in the market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.Read the full report: https://www.reportlinker.com/p06033663/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001